Editor’s note: Jim Manzi is the author of “Uncontrolled: the Surprising Payoff of Trial-and-Error for Business, Politics, and Society.” He is the founder and chairman of Applied Predictive Technologies, a global provider of predictive analytics software. Manzi is a senior fellow at the Manhattan Institute and a contributing editor at...

As regulators seek to weigh the potential benefits and risks of a new medicine, my own observation is that they tend to be both tentative and ultra-paternalistic.

Arthur Brooks and Jim Manzi are intellectual heirs to Hayek; they are admirably recapturing old truths handed down from America’s Founders and restating them for today’s generation.

Cosponsored by AEI and the Engelberg Center for Health Care Reform at Brookings Institution, this conference on regulating medical devices will convene stakeholders to discuss current challenges and feasible solutions that protect public health while encouraging the development, approval, and reimbursement of effective technologies.

Elections in Taiwan are increasingly about which candidate can successfully engage China while protecting Taiwan's status.

The FDA is restricting the speech of private drug firms. This may violate the First Amendment rights of drugs companies.

Ave Maria University and it's professors have mixed feelings about Jackson labs not constructing a location nearby.

How do supplemental educationonial services impact student achievement and what makes SES effective or why does it fails?